Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy

• Status: Completed
• Trial end date: 1969-12-31

Summary

The study searched for answers to two questions

1. Is there endothelial dysfunction, inflammation and insulin resistance in patients with congenital hypogonadotropic hypogonadism?

2. What is the effect of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resistance?

• Phase: Phase 4

Details

• Lead Sponsor: Gulhane School of Medicine
• Treatments: Insulin; Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate